CYP1A1 gene polymorphisms: Lack of Association with Breast Cancer Susceptibility in the Southern Region (Madurai) of India

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 8, 2011, Pages 2133-2138

  Kiruthiga, P V ^a   Rajesh Kannan, M ^a   Saraswathi, C ^a   Karutha Pandian, S ^a   Pandima Devi, K ^a  

^a ALAGAPPA UNIVERSITY   (India)

Author keywords

Breast cancer; CYP 1A1; M1 and M2 polymorphisms; South Indian population

Indexed keywords

EID: 84858117344     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Ambrosone CB, Freudenheim JL, Graham S, et al. (1995). Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res, 55, 3483-?.
2. Bailey LR, Roodi N, Verrier CS, et al. (1998). Breast cancer and CYPIA1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans. Cancer Res, 58, 65-?.
3. Basham VM, Pharoah PDP, Healey C. (2001). Polymorphisms in CYP1A1 and smoking: no association with breast cancer risk. Carcinogenesis, 22, 1797-?.
4. Boyapati SM, Shu XO, Gao YT, et al. (2005). Polymorphisms in CYP1A1 and breast carcinoma risk in a population based case-control study of Chinese women. Cancer, 103, 2228-35.
5. Camitta BM, Pullen J, Murphy S. (1997). Biology and treatment of acute lymphocytic leukemia in children. Semin Oncol, ?, 83.
6. Cascorbi I, Brockmöller J, Roots I. (1996). A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res, 56, 4965-?.
7. Chacko P, Joseph T, Mathew BS, et al. (2005). Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome. Mutat Res-Gen Tox En, 581, 153-63.
8. Chen C, Huang Y, Li Y, et al. (2007). Cytochrome P450 1A1 (CYP1A1) T3801C and A2455G polymorphisms in breast cancer risk: a meta-analysis. J Hum Genet, 52, 423-35.
9. Colditz GA. (1993). Epidemiology of breast cancer: findings from the Nurses' Health Study. Cancer, 71, 1480-9.
10. Crofts F, Cosma GN, Currie D, et al. (1993). A novel CYP1A1 gene polymorphism in African-Americans. Carcinogenesis, 14, 1729-?.
11. Crofts F, Taioll E, Trachman J, et al. (1994). Functional significance of different human CYPlAl genotypes. Carcinogenesis, 15, 2961-?.
12. da Fonte de Amorim LM, Rossini A, Mendonça GAS, et al. (2002). CYP1A1, GSTM1, and GSTT1 polymorphisms and breast cancer risk in Brazilian women. Cancer Lett, 181, 179-86.
13. Hayashi SI, Watanabe J, Nakachi K, et al. (1991). PCR detection of an A/G polymorphism within exon 7 of the CYP1A1 gene. Nucleic Acids Res, 19, 4797.
14. Hefler LA, Tempfer CB, Grimm C, et al. (2004). Estrogen metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women. Cancer, 101, 264-9.
15. Huang CS, Shen CY, Chang KJ, et al. (1999). Cytochrome P4501A1 polymorphism as a susceptibility factor for breast cancer in postmenopausal Chinese women in Taiwan. Br J Cancer, 80, 1838.
16. Jeffreys AJ, Morton DB. (1987). DNA fingerprints of dogs and cats. Anim Genet, 18, 1-15.
17. Kawajiri K, Nakachi K, Imai K, et al. (1990). Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P45 0IA1 gene. FEBS Lett, 263, 131-3.
18. Kelsey JL, Bernstein L. (1996). Epidemiology and prevention of breast cancer. Ann Review Public Health, 17, 47-67.
19. Kiyohara C, Hirohata T, Inutsuka S. (1996). The relationship between aryl hydrocarbon hydroxylase and polymorphisms of the CYP1A1 gene. Cancer Sci, 87, 18-24.
20. Krajinovic M, Ghadirian P, Richer C, et al. (2001). Genetic susceptibility to breast cancer in French Canadians: Role of carcinogen metabolizing enzymes and gene-environment interactions. Int J Cancer, 92, 220-5.
21. Le Marchand L, Donlon T, Kolonel LN, et al. (2005). Estrogen metabolism-related genes and breast cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev, 14, 1998-?.
22. Li Y, Millikan RC, Bell DA, Cui L, et al. (2004). Cigarette smoking, cytochrome P4501A1 polymorphisms, and breast cancer among African-American and white women. Breast Cancer Res, 6, R460-73.
23. Mahmoud S, Labib DA, Khalifa RH, et al. (2010). CYP1A1, GSTM1 and GSTT1 genetic polymorphism in Egyptian chronic myeloid leukemia patients. RJI, 3, 12-21.
24. Masson LF, Sharp L, Cotton SC, et al. (2005). Cytochrome P-450 1A1 gene polymorphisms and risk of breast cancer: a HuGE review. Am J Epidemiol, 161, 901.
25. Miyoshi Y, Takahashi Y, Egawa C, et al. (2002). Breast cancer risk associated with CYP1A1 genetic polymorphisms in Japanese women. Breast J, 8, 209-15.
26. Nebert DW, Dalton TP, Okey AB, et al. (2004). Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J Biol Chem, 279, 23847-?.
27. Perera FP, Estabrook A, Hewer A, et al. (1995). Carcinogen-DNA adducts in human breast tissue. Cancer Epidemiol Biomarkers Prev, 4, 233-?.
28. Rozati R, Satyanarayana Reddy B, Giragalla SB, et al. (2008). The CYP1A1 and GSTM1 genetic polymorphisms and susceptibility to endometriosis in women from South India. IJFS, 2, 105-12.
29. Shen Y, Li DK, Wu J, et al. (2006). Joint effects of the CYP1A1 MspI, ER PvuII, and ER XbaI polymorphisms on the risk of breast cancer: results from a population-based case-control study in Shanghai, China. Cancer Epidemiol Biomarkers Prev, 15, 342-?.
30. Shin A, Kang D, Choi JY, et al. (2007). Cytochrome P450 1A1 (CYP1A1) polymorphisms and breast cancer risk in Korean women. Exp Mol Med, 39, 361-?.
31. Singh N, Mitra AK, Garg VK, et al. (2007a). Association of CYP1A1 polymorphisms with breast cancer in North Indian women. Oncol Res, 16, 587-97.
32. Singh V, Rastogi N, Sinha A, et al. (2007b). A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women. Breast Cancer Res Treat, 101, 73-81.
33. Surekha D, Sailaja K, Rao DN, et al. (2009). Association of CYP1A1* 2 polymorphisms with breast cancer risk: A case control study. Indian J Med Sci, 63, 13-?.
34. Syamala VS, Syamala V, Sheeja VR, et al. (2010). Possible risk modification by polymorphisms of estrogen metabolizing genes in familial breast cancer susceptibility in an Indian population. Cancer Invest, 28, 304-311.
35. Taioli E, Bradlow HL, Garbers SV, et al. (1999). Role of estradiol metabolism and CYP1A1 polymorphisms in breast cancer risk. Cancer Detect Prev, 23, 232-?.
36. Zhang Y, Wise JP, Holford TR, et al. (2004). Serum polychlorinated biphenyls, cytochrome P-450 1A1 polymorphisms, and risk of breast cancer in Connecticut women. Am J Epidemiol, 160, 1177-?.